Stem Cell Reconstructive Market Research Report - Forecast to 2027

Stem Cell Reconstructive Market Research Report: By Sources (Allogeneic, Autologous, Syngeneic And Other), Cell Types (Embryonic Stem Cell, Adult Stem Cell), Application (Cancer, Diabetes, Traumatic Skin Defect, Severe Burn), End Users (Hospital, Research Institutes) - Forecast Till 2027

ID: MRFR/LS/0487-HCR | February 2021 | Region: Global | 110 pages

Stem Cell Reconstructive Market overview


Stem cell surgery is for to treat the damaged part of the body. Stem cells are generally undifferentiated biological cells. These cells divide to generate more stem cells.  An increasing geriatric population and rising number of patients suffering from various diseases, and the Advancement of technology are boosting the stem-cell reconstructive and plastic surgery demand and growing reconstructive surgeries among patients due to rising number of limbs elimination, implants, and accident boosting the Stem cell reconstructive market growth.  Apart from that, stem cell reconstructive breast surgery is a very common treatment used in case of certain problems.  The demand for Stem cell reconstructive surgery market is increasing every day with an increasing number of the aged population.


Stem cell reconstructive is a treatment procedure that uses the patient’s own adipose tissue to increase the fat volume in a particular area of a body. The Stem cell reconstructive is also help in the 3Dimentional reconstruction process in the patients who have gone through trauma or in the past surgical phase such as lumpectomy, reconstructive surgery, brain surgery as a result of an accident.   Stem cell reconstructive treatment is also a part of plastic surgeries as well. Stem cell reconstructive can give many benefits to patients going through a variety of conditions and symptoms.  Stem cell reconstructive therapy so considered regenerative medicine, and it promotes the repair of patients by using stem cells.


The Stem cell reconstructive market report is expected to grow at 22.6% CAGR in the forecast period 2017-2023 due to the adoption of Stem cell reconstructive surgery in a variety of conditions. Stem cell reconstructive surgery is used to treat cardiovascular diseases in which the disease can cause scar tissue. And it is also used to heal wounds and incisions. As Stem cell reconstructive surgery can enhance the growth of new skin tissue, and enhance collagen production, substitute the scar tissue, so it is widely used to treat many medical conditions. Stem cell reconstructive therapy is also used in the treatment of neurodegenerative diseases. Transplanted new adult cells can work in the formation of new brain neurons and cells. A wide range of applications of Stem cell reconstructive will boost the Stem cell reconstructive Industry.


Covid-19 analysis


The covid-19 outbreak was due to the spread of deadly coronavirus, and it is now a global pandemic. Many people are suffering because of the financial crisis and the downfall of the global economy. Businesses around the world are highly affected due to the pandemic. As a result, it has a negative impact on the Stem cell reconstructive market and the allogeneic stem cells market as well.  The cost of stem-cell reconstructive and plastic surgery is very high; as a result, people can’t afford the treatment due to the financial crisis. Many people have lost their jobs and source of income, so they are not ready to invest in such a procedure. Apart from that, hospitals are not more concerned about the spread of coronavirus, and they are fighting against it. All focus has shifted in controlling the spread of the virus; as a result, it is affecting the Stem cell reconstructive industry.  Also, the imposition of lockdown by the government in many countries has also affected the Stem cell reconstructive market growth. 


Figure 1- Global Stem Cell Reconstructive Market, by region


 stem cell reconstructive market


Source- Annual reports, white paper, company presentation


Market segmentation


The Stem cell reconstructive is growing due to the presence of market drivers like that the presence of the market restraints hampering the Stem cell reconstructive industry demand.


Market drivers


The stem cell is a cell that is capable of perpetuating its cell division and has the ability to produce cells with specialized functions. Stem cells are used in the treatment of major diseases such as diabetes, cancer, and others. Stem cells have shown great results for the diseases. According to the data of the international diabetes federation, 420 people were suffering from diabetes across the world. And the increasing patient population has increased the demand for new treatment methods that is a major driver in the Stem cell reconstructive industry. The Advancement of technology and increasing investment in the healthcare sectors by government and other government initiatives are contributing highly to the Stem cell reconstructive market growth.  Stem cell reconstructive also used to treat the dented or injured part of the body due to accidents or other diseases.


Market opportunities


The government is taking many initiatives to provide the best healthcare possible to the patients, and it is generating new opportunities for the Stem cell reconstructive market. Stem cell reconstructive is used to treat various diseases in an effective way; that is why the hospitals are adopting these advanced treatments to provide effective healthcare to the patients. Stem cell reconstructive is also used in cosmetic surgeries and plastic surgeries as a result of an accident or injury. Stem cell reconstructive therapy offers effective solutions in plastic surgery. And with the increasing need for plastic surgery bringing more opportunities to the Stem cell reconstructive industry. Apart from that, with changing lifestyles and increasing per capita income, people can invest in cosmetic surgery or Stem cell reconstructive surgery. So, Economic development is also generating Stem cell reconstructive industry opportunities.


Market restraints


Stem cell reconstructive is very costly, and the high expenditure has become one of the major restraints of the Stem cell reconstructive market. Apart from that, new government regulations on the approval of Stem cell reconstructive has also become a restraint in the Stem cell reconstructive market.


Market challenges


The Stem cell reconstructive market faces challenges just like other markets. There are many underdeveloped areas where advanced treatment procedure is not available due to lack of Technological Advancement, and it has become a major challenge for the Stem cell reconstructive market. The market key players and the drivers are likely to overcome these challenges and boost the Stem cell reconstructive market Demand in the forecast period.


Cumulative growth analysis


Stem cell reconstructive market is expected to register a CAGR of 22.6%. The wide range of applications of Stem cell reconstructive treating various diseases and health conditions will drive the Stem cell reconstructive market in the forecast period.


Market segmentation


The Stem cell reconstructive market is divided on the basis of sources, cell types, applications, end-users, and regions.



  • By sources


On the basis of sources, the market is further divided into allogeneic, syngeneic, autologous, and others.  Autologous is further divided into adipose tissue, bone marrow, and blood.



  • By cell types


On the basis of cell types, the market is divided into embryonic stem cells and adult stem cells.



  • By application


Stem cell reconstructive market application segment divided on the basis of cancer, severe burn, diabetes, traumatic skin defect, and others.



  • By end-user


On the basis of end-user, the market is divided into hospitals, research institutes, and others.



  • By regions


The region segment of the market includes North America, Europe, Asia Pacific, and the rest of the world.


Regional analysis


The major regions in the Stem cell reconstructive market are North America, Europe, Asia Pacific, and the rest of the world. The North American region holds the highest Stem cell reconstructive market share due to the advanced healthcare sector and a large patient pool. A large number of patients in Canada and the US also a high percentage of cancer & diabetes patients driving the Stem cell reconstructive industry in this region. Also, strong economy is another driver in the growth of the Stem cell reconstructive industry in this region.


Europe holds the second highest Stem cell reconstructive industry share due to the high investment in stem cell research. Further, the identification of new cells will boost the Stem cell reconstructive market. No regulations and the high amount of funding is one of the major drivers behind the Stem cell reconstructive industry growth in this region.


The Asia Pacific is still developing with the increasing demand for Stem cell reconstructive surgeries in the countries like Japan and Australia, and also increasing the number of cell suppliers in China, India, and Australia will boost the market in the coming years. Government and private partnership agreements and increasing cell-based research will propel the Stem cell reconstructive industry in the forecast period.


Competitive landscape


The major key players in the Stem cell reconstructive market are:



  • Cynata (Australia),

  • Celyad (Belgium),

  • Capricor Therapeutics (Canada),

  • Micronit Microfluidics (Netherlands),

  • TAKARA BIO INC.(Japan),

  • Tigenix (Belgium) Baxter (US),

  • Cytori Therapeutics Inc. (US),

  • Eleveflow (France),

  • Mesoblast Ltd. (Australia),

  • NuVasive Inc. (US),

  • Osiris Therapeutics, Inc. (US)

  • Pfizer Inc. (US)


Recent developments


San Diego Academy of Regenerative Therapies Features Update on Clinical Trial Treating Post COVID Patients with the help of cells from fat tissue.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   22.6% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Sources, Cell Types, Application, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Baxter (US), Cytori Therapeutics Inc. (U.S), Eleveflow (France), Mesoblast Ltd. (Australia), NuVasive Inc. (US), Osiris Therapeutics, Inc. (US), Micronit Microfluidics (Netherlands), TAKARA BIO INC.(Japan), Tigenix (Belgium), Cynata (Australia), Celyad (Belgium), Capricor Therapeutics (Canada), Astellas Pharma US, Inc. (US), Pfizer Inc. (US), StemCells Inc (US), STEMCELL Technologies Inc. (US), Caladrius (US).
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing number of geriatric population
  • Rising number of patients suffering from chronic diseases
  • Continuous development in the technology.


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Stem cell reconstructive surgery uses stem cells to replace injured body parts. As stem cells can take on the form of any human cell, this technique has gained popularity in the medical sector.

    The Stem Cell Reconstructive Market is expected to exhibit a strong 22.6% CAGR over the forecast period from 2017 to 2023.

    Growing investigation into the remedial capabilities of stem cells is the major driver for the Global Stem Cell Reconstructive Market.

    The Americas hold a dominant 45% share in the global market.

    Leading players in the Stem Cell Reconstructive Market include Baxter, Eleveflow, and Mesoblast Ltd., among others.

    TABLE OF CONTENTS

    1 INTRODUCTION

    1.1 DEFINITION

    1.2 SCOPE OF STUDY

    1.2.1 RESEARCH OBJECTIVE

    1.2.2 ASSUMPTIONS & LIMITATIONS

    1.2.2.1 ASSUMPTIONS

    1.2.2.2 LIMITATIONS

    1.3 MARKET STRUCTURE

    2 RESEARCH METHODOLOGY

    2.1 RESEARCH PROCESS:

    2.2 PRIMARY RESEARCH

    2.3 SECONDARY RESEARCH:

    3 MARKET DYNAMICS

    3.1 DRIVERS

    3.2 RESTRAINTS

    3.3 OPPORTUNITIES

    3.4 MACROECONOMIC INDICATORS

    4 MARKET FACTOR ANALYSIS

    4.1 PORTERS FIVE FORCES MODEL

    4.2 BARGAINING POWER OF SUPPLIERS

    4.3 BARGAINING POWER OF BUYERS

    4.4 THREAT OF NEW ENTRANTS

    4.5 THREAT OF SUBSTITUTES

    4.6 INTENSITY OF RIVALRY

    5. GLOBAL STEM CELL RECONSTRUCTIVE MARKET, BY SOURCES

    5.1 ALLOGENEIC

    5.2 AUTOLOGOUS

    5.2.1 BONE MARROW

    5.2.2 ADIPOSE TISSUE

    5.2.3 BLOOD

    5.3 SYNGENEIC

    5.4 OTHER

    6. GLOBAL STEM CELL RECONSTRUCTIVE MARKET, BY CELL TYPES

    6.1 EMBRYONIC STEM CELL

    6.2 ADULT STEM CELL

    7. GLOBAL STEM CELL RECONSTRUCTIVE MARKET, BY APPLICATION

    7.1 CANCER

    7.2 DIABETES

    7.3 TRAUMATIC SKIN DEFECT

    7.4 SEVERE BURN

    7.5 OTHER

    8 GLOBAL STEM CELL RECONSTRUCTIVE MARKET, BY END USER

    8.1 HOSPITALS

    8.2 RESEARCH INSTITUTE

    8.3 OTHERS

    9. GLOBAL STEM CELL RECONSTRUCTIVE MARKET, BY REGION

    9.1 INTRODUCTION

    9.2 AMERICA

    9.2.1 NORTH AMERICA

    9.2.1.1 US

    9.2.1.2 CANADA

    9.2.2 SOUTH AMERICA

    9.3 EUROPE

    9.3.1 WESTERN EUROPE

    9.3.1.1 GERMANY

    9.3.1.2 FRANCE

    9.3.1.3 ITALY

    9.3.1.3 SPAIN

    9.3.1.5 UK

    9.3.1.6 REST OF WESTERN EUROPE

    9.3.2 EASTERN EUROPE

    9.4 ASIA PACIFIC

    9.4.1 JAPAN

    9.4.2 CHINA

    9.4.3 INDIA

    9.4.4 AUSTRALIA

    9.4.5 REPUBLIC OF KOREA

    9.4.6 REST OF ASIA-PACIFIC

    9.5 MIDDLE EAST & AFRICA

    9.5.1 UNITED ARAB EMIRATES

    9.5.2 SAUDI ARABIA

    9.5.3 OMAN

    9.5.4 KUWAIT

    9.5.5 QATAR

    9.5.6 REST OF MIDDLE EAST & AFRICA

    10. COMPETITIVE LANDSCAPE

    10.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

    10.1.1 STRATEGIC PARTNERSHIP

    10.1.2 MERGER & ACQUISITION

    11 COMPANY PROFILE

    11.1 CYTORI THERAPEUTICS INC

    11.1.1 OVERVIEW

    11.1.2 PRODUCT OVERVIEW

    11.1.3 FINANCIALS

    11.1.4 KEY DEVELOPMENTS

    11.2 ELEVEFLOW

    11.2.1 OVERVIEW

    11.2.2 PRODUCT OVERVIEW

    11.2.3 FINANCIALS

    11.2.4 KEY DEVELOPMENTS

    11.3 MICRONIT MICROFLUIDICS

    11.3.1 OVERVIEW

    11.3.2 PRODUCT OVERVIEW

    11.3.3 FINANCIALS

    11.3.4 KEY DEVELOPMENT

    11.4 CYNATA THERAPEUTICS

    11.4.1 OVERVIEW

    11.4.2 PRODUCT OVERVIEW

    11.4.3 FINANCIALS

    11.4.4 KEY DEVELOPMENTS

    11.5 CELYAD

    11.5.1 OVERVIEW

    11.5.2 PRODUCT OVERVIEW

    11.5.3 FINANCIALS

    11.5.4 KEY DEVELOPMENTS

    11.6 BAXTER

    11.6.1 OVERVIEW

    11.6.2 PRODUCT OVERVIEW

    11.6.3 FINANCIALS

    11.6.4 KEY DEVELOPMENTS

    11.7 MESOBLAST LTD

    11.7.1 OVERVIEW

    11.7.2 PRODUCT OVERVIEW

    11.7.3 FINANCIALS

    11.7.4 KEY DEVELOPMENTS

    11.8 NUVASIVE INC

    11.8.1 OVERVIEW

    11.8.2 PRODUCT OVERVIEW

    11.8.3 FINANCIALS

    11.8.4 KEY DEVELOPMENTS

    11.9 OSIRIS

    11.9.1 OVERVIEW

    11.9.2 PRODUCT OVERVIEW

    11.9.3 FINANCIALS

    11.9.4 KEY DEVELOPMENTS

    11.10 PFIZER INC

    11.10.1 OVERVIEW

    11.10.2 PRODUCT OVERVIEW

    11.10.3 FINANCIALS

    11.10.4 KEY DEVELOPMENTS

    11.11 OTHERS

    12 CONCLUSION

    13.1 KEY FINDINGS

    13.1.1 FROM CEO’S VIEWPOINT

    13.1.2 UNMET NEEDS OF THE MARKET

    13.2 KEY COMPANIES TO WATCH

    13.3 PREDICTION OF LIFE SCIENCE INDUSTRY

    14 APPENDIX

    LIST OF TABLES

    Table 1 Stem Cell Reconstructive Industry Synopsis, 2020-2027

    Table 2 Global Stem Cell Reconstructive Market Estimates & Forecast, 2020-2027, (USD Million)

    Table 3 Global Stem Cell Reconstructive Market, by Region, 2020-2027, (USD Million)

    Table 4 Global Stem Cell Reconstructive Market, by Source, 2020-2027, (USD Million)

    Table 5 Global Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 6 Global Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 7 Global Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million)

    Table 8 North America Stem Cell Reconstructive Market, by Source, 2020-2027, (USD Million)

    Table 9 North America Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 10 North America Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 11 North America Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million)

    Table 12 U.S. Stem Cell Reconstructive Market, by Source, 2020-2027, (USD Million)

    Table 13 U.S. Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 14 U.S. Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 15 U.S. Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million)

    Table 16 Canada Stem Cell Reconstructive Market, by Source, 2020-2027, (USD Million)

    Table 17 Canada Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 18 Canada Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 19 Canada Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million)

    Table 20 South America Stem Cell Reconstructive Market, by Source, 2020-2027, (USD Million)

    Table 21 South America Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 22 South America Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 23 South America Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million)

    Table 24 Europe Stem Cell Reconstructive Market, by Source, 2020-2027, (USD Million)

    Table 25 Europe Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 26 Europe Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 27 Europe Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million)

    Table 28 Western Europe Stem Cell Reconstructive Market by Source, 2020-2027, (USD Million)

    Table 29 Western Europe Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 30 Western Europe Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 31 Western Europe Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million)

    Table 32 Eastern Europe Stem Cell Reconstructive Market, by Source, 2020-2027, (USD Million)

    Table 33 Eastern Europe Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 34 Eastern Europe Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 35 Eastern Europe Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million)

    Table 36 Asia Pacific Stem Cell Reconstructive Market, by Source, 2020-2027, (USD Million)

    Table 37 Asia Pacific Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 38 Asia Pacific Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 39 Asia Pacific Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million)

    Table 40 Middle East & Africa Stem Cell Reconstructive Market, by Source, 2020-2027, (USD Million)

    Table 41 Middle East & Africa Stem Cell Reconstructive Market, by Cell Type, 2020-2027, (USD Million)

    Table 42 Middle East & Africa Stem Cell Reconstructive Market, by Application, 2020-2027, (USD Million)

    Table 43 Middle East & Africa Stem Cell Reconstructive Market, by End-User, 2020-2027, (USD Million) 


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Stem Cell Reconstructive Market

    Figure 3 Segmentation Market Dynamics for Stem Cell Reconstructive Market

    Figure 4 Global Stem Cell Reconstructive Market Share, by Source 2020

    Figure 5 Global Stem Cell Reconstructive Market Share, by Cell Type 2020

    Figure 6 Global Stem Cell Reconstructive Market Share, by Application 2020

    Figure 7 Global Stem Cell Reconstructive Market Share, by End User, 2020

    Figure 8 Global Stem Cell Reconstructive Market Share, by Region, 2020

    Figure 9 North America Stem Cell Reconstructive Market Share, by Country, 2020

    Figure 10 Europe Stem Cell Reconstructive Market Share, by Country, 2020

    Figure 11 Asia Pacific Stem Cell Reconstructive Market Share, by Country, 2020

    Figure 12 Middle East & Africa Stem Cell Reconstructive Market Share, by Country, 2020

    Figure 13 Global Stem Cell Reconstructive Market: Company Share Analysis, 2020 (%)